Chinese-made COVID-19 mRNA vaccine starts trial production
SHANGHAI — China’s CanSino Biologics Inc has entered the “test production phase” for its COVID-19 mRNA booster vaccine, the company said in a post on its social media account late on Thursday. The vaccine, known as CS-2034, targets new Omicron variants of the virus, which are responsible for the vast majority of infections that have […]
The post Chinese-made COVID-19 mRNA vaccine starts trial production appeared first on Inquirer News.
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.